Halberd Corp. is a development stage company, researches and develops antibodies and devices for the prevention, detection, and treatment of Covid-19 through laboratory, hospital, and clinical trials. It offers patented extracorporeal treatment that is applicable to various blood-borne and neurologic diseases, including Covid-19, other viruses, PTSD, cancer, etc. The company was founded by Lundquist Mark Sven and Maddox John Christopher on January 26, 2009 and is headquartered in Jackson Center, PA.